ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0229

Effect of Extended-Hours Hemodialysis on Hepcidin-25 and Iron Metabolism

Session Information

Category: Anemia and Iron Metabolism

  • 200 Anemia and Iron Metabolism

Authors

  • Nishibori, Nobuhiro, Nagoya Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Nagoya, Aichi Prefecture, Japan
  • Okazaki, Masaki, Nagoya Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Nagoya, Aichi Prefecture, Japan
  • Imaizumi, Takahiro, Nagoya Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Nagoya, Aichi Prefecture, Japan
  • Yamada, Takumi, Nagoya Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Nagoya, Aichi Prefecture, Japan
  • Kaneda, Fumika, Iryo Hojin Kamome Clinic, Iwaki, Fukushima Prefecture, Japan
  • Kasuga, Hirotake, Nagoya Kyoritsu Byoin, Nagoya, Aichi Prefecture, Japan
  • Maruyama, Shoichi, Nagoya Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Nagoya, Aichi Prefecture, Japan
Background

In patients on maintenance hemodialysis (HD), elevated interleukin 6 (IL-6) levels due to chronic inflammation promote hepcidin synthesis and cause anemia due to impaired iron utilization. Extended-hours HD is known to reduce erythropoietin dose, but the mechanism is unknown. The aim of this study is to investigate the impact of extended-hours HD on hepcidin and iron metabolism.

Methods

Patients on extended-hours or conventional HD between January and March 2020 were included, and hepcidin-25 and IL-6 levels were measured in pre-dialysis samples. Multivariable linear regression were performed to investigate the impact of extended-hours HD on hepcidin-25 and ferritin levels. In addition, mediation analysis were performed using hepcidin-25 as mediator to assess the association between extended-hours HD and ferritin levels.

Results

A total of 380 participants (183 on extended-hours HD and 197 on conventional HD) were included in the analysis. The mean of age (years), hemoglobin (g/dL), and ferritin (ng/dL) levels was 66, 10.9 and 51.7 in extended-hours HD group, and 72, 11.2 and 90.9 in conventional HD group. Figure A&B indicated that weekly ESAs dose and hepcidin-25 levels were lower in extended-hours HD grop. Figure C indicated that extended-hours HD was associated with lower hepcidin-25 levels, regardless of IL-6 levels. Multivariable linear regression analysis showed that extended-hours HD was associated with lower hepcidin-25 levels; -15.6 ng/mL (95% confidence interval (CI); -22.9 to -8.4), and lower ferritin levels; -35.7 ng/dL (95% CI; -55.14 to -16.2). By mediation analysis, the proportion of mediating effect of hepcidin-25 was 68.0%, and mediation effect was statistically significant.

Conclusion

Extended-hours HD was associated with lower hepcidin-25 levels, which significantly mediated lower ferritin levels. These changes in iron metabolism may contribute to better clinical outcomes in patients on extended-hours HD.

Digital Object Identifier (DOI)